In conclusion, we have used genetic determinants of alternative splicing and COVID-19 outcomes obtained from large-scale studies and found compelling evidence that splicing events in OAS1, ATP11A, DPP9, NPNT, MUC1, and PMF1 have causal effects on COVID-19 severity and susceptibility. The gene discussed is PMF1; the disease is COVID-19.